A Study of Subcutaneous (SC) AMG 701 in Participants With Relapsed or Refractory Multiple Myeloma (RRMM)

Clinical trial NCT04998747 · WITHDRAWN

Trial details

NCT number: NCT04998747
Sponsor: Amgen
Status: WITHDRAWN
Phase: Phase 1
Study type: INTERVENTIONAL

Relapsed/Refractory Multiple Myeloma

Start date: 2023-08-29
Primary completion: 2025-08-02
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.